People

John Ainslie

John Ainslie is a member of Yosemite’s life-sciences investment team, identified as an analyst in Texas Biomedical Research Institute’s March2025 primary Global Health Symposium programme. SOCAP’s own panel proposal likewise identifies him as an analyst at Yosemite, previously Emerson Collective. His public professional profile identifies University of Pennsylvania and biotech/investment society participation; his own2023 launch post confirms membership of the founding team. Exact current rank and tenure days are unpublished.